Anaeropharma Science announces appointment of new Board Director

Dr. Yoshimatsu has been named the new Board Director of Anaeropharma Science. He started this new role from March 2018. Prior to this, he spent 40 years in leading research activities mainly in the oncology area at Eisai, one of the leading Japanese pharmaceutical companies.

Comments are closed.